Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
13.67
+1.42 (11.59%)
At close: May 12, 2025, 4:00 PM
13.49
-0.18 (-1.32%)
After-hours: May 12, 2025, 6:50 PM EDT
IART Market Cap
IART has a market cap or net worth of $1.06 billion as of May 12, 2025. Its market cap has decreased by -53.77% in one year.
Market Cap
1.06B
Enterprise Value
2.81B
1-Year Change
-53.77%
Ranking
Category
Stock Price
$13.67
Market Cap Chart
Since December 1, 1998, IART's market cap has increased from $68.40M to $1.06B, an increase of 1,453.11%. That is a compound annual growth rate of 10.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 952.00M | -45.60% |
Dec 31, 2024 | 1.75B | -48.60% |
Dec 29, 2023 | 3.40B | -27.30% |
Dec 30, 2022 | 4.68B | -17.47% |
Dec 31, 2021 | 5.67B | 3.71% |
Dec 31, 2020 | 5.47B | 9.33% |
Dec 31, 2019 | 5.00B | 30.27% |
Dec 31, 2018 | 3.84B | 2.28% |
Dec 29, 2017 | 3.76B | 17.10% |
Dec 30, 2016 | 3.21B | 27.95% |
Dec 31, 2015 | 2.51B | 40.98% |
Dec 31, 2014 | 1.78B | 32.57% |
Dec 31, 2013 | 1.34B | 27.26% |
Dec 31, 2012 | 1.05B | 27.46% |
Dec 30, 2011 | 826.90M | -38.13% |
Dec 31, 2010 | 1.34B | 27.27% |
Dec 31, 2009 | 1.05B | 6.79% |
Dec 31, 2008 | 983.30M | -11.05% |
Dec 31, 2007 | 1.11B | -6.54% |
Dec 29, 2006 | 1.18B | 18.91% |
Dec 30, 2005 | 994.70M | -6.60% |
Dec 31, 2004 | 1.07B | 36.87% |
Dec 31, 2003 | 778.10M | 62.88% |
Dec 31, 2002 | 477.70M | -29.40% |
Dec 31, 2001 | 676.60M | 189.39% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 673.75B |
Johnson & Johnson | 372.20B |
UnitedHealth Group | 342.74B |
AbbVie | 337.79B |
Novo Nordisk | 292.03B |
Abbott Laboratories | 230.49B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |